(Reuters) -Scholar Rock said on Tuesday the U.S. health regulator has declined to approve its drug for a rare neuromuscular disease citing issues at a third-party manufacturing facility, sending the ...
Drugs such as Wegovy and Ozempic can lead to profound weight loss, but fat isn’t the only thing that comes off. About 25 to ...